The Cooper Companies, Inc.

NasdaqGS COO

The Cooper Companies, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending October 31, 2024: 4.98%

The Cooper Companies, Inc. Return on Equity (ROE) is 4.98% for the Trailing 12 Months (TTM) ending October 31, 2024, a 26.09% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

The Cooper Companies, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending October 31, 2023 was 3.95%, a -27.85% change year over year.
The Cooper Companies, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending October 31, 2022 was 5.47%, a -87.97% change year over year.
The Cooper Companies, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending October 31, 2021 was 45.51%, a 613.22% change year over year.
The Cooper Companies, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending October 31, 2020 was 6.38%, a -51.42% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

NasdaqGS: COO

The Cooper Companies, Inc.

CEO	Mr. Albert G. White III
IPO Date	Jan. 21, 1983
Location	United States
Headquarters	6101 Bollinger Canyon Road
Employees	15,000
Sector	Consumer Discretionary
Industries Eyewear Cosmetics

Description

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Key trends

Past 5 years